Heat-killed Lactobacillus reuteri and cell-free culture supernatant have similar effects to viable probiotics during interaction with Porphyromonas gingivalis

Journal of Periodontal Research

Volumn 55, Issue 2, 2020, Pages 215-220

  Geraldo, Barbara M C ^a   Batalha, Marianna N ^a   Milhan, Noala V M ^a   Rossoni, Rodnei D ^a   Scorzoni, Liliana ^a   Anbinder, Ana Lia ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Galleria mellonella; Lactobacillus reuteri; Paraprobiotics; Porphyromonas gingivalis; probiotics

Indexed keywords

PROBIOTIC AGENT;

ANIMAL; CONDITIONED MEDIUM; DRUG EFFECT; HEAT; LACTOBACILLUS REUTERI; MOTH; PATHOGENICITY; PHARMACOLOGY; PORPHYROMONAS GINGIVALIS;

ANIMALS; CULTURE MEDIA, CONDITIONED; HOT TEMPERATURE; LACTOBACILLUS REUTERI; MOTHS; PORPHYROMONAS GINGIVALIS; PROBIOTICS;

EID: 85074929662     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/jre.12704     Document Type: Article

References (36)

1. Oh PL, Benson AK, Peterson DA, et al. Diversification of the gut symbiont Lactobacillus reuteri as a result of host-driven evolution. ISME J. 2010;4:377-387.
2. Talarico TL, Dobrogosz WJ. Chemical characterization of an antimicrobial substance produced by Lactobacillus reuteri. Antimicrob Agents Chemother. 1989;33:674-679.
3. Mu Q, Tavella VJ, Luo XM. Role of Lactobacillus reuteri in human health and diseases. Front Microbiol. 2018;9:1-17.
4. Theodoro LH, Cláudio MM, Nuernberg M, et al. Effects of Lactobacillus reuteri as an adjunct to the treatment of periodontitis in smokers: randomised clinical trial. Benef Microbes. 2019;10:375-384.
5. Soares LG, De Carvalho EB, Tinoco E. Clinical effect of Lactobacillus on the treatment of severe periodontitis and halitosis: a double-blinded, placebo-controlled, randomized clinical trial. Am J Dent. 2019;32:9-13.
6. Galofré M, Palao D, Vicario M, Nart J, Violant D. Clinical and microbiological evaluation of the effect of Lactobacillus reuteri in the treatment of mucositis and peri-implantitis: a triple-blind randomized clinical trial. J Periodontal Res. 2018;53:378-390.
7. Flichy-Fernández AJ, Ata-Ali J, Alegre-Domingo T, et al. The effect of orally administered probiotic Lactobacillus reuteri-containing tablets in peri-implant mucositis: a double-blind randomized controlled trial. J Periodontal Res. 2015;50:775-785.
8. Tekce M, Ince G, Gursoy H, et al. Clinical and microbiological effects of probiotic lozenges in the treatment of chronic periodontitis: a 1-year follow-up study. J Clin Periodontol. 2015;42:363-372.
9. İnce G, Gürsoy H, İpçi ŞD, Cakar G, Emekli-Alturfan E, Yılmaz S. Clinical and biochemical evaluation of lozenges containing Lactobacillus reuteri as an adjunct to non-surgical periodontal therapy in chronic periodontitis. J Periodontol. 2015;86:746-754.
10. Szkaradkiewicz AK, Stopa J, Karpiński TM. Effect of oral administration involving a probiotic strain of Lactobacillus reuteri on pro-inflammatory cytokine response in patients with chronic periodontitis. Arch Immunol Ther Exp. 2014;62:495-500.
11. Teughels W, Durukan A, Ozcelik O, Pauwels M, Quirynen M, Haytac MC. Clinical and microbiological effects of Lactobacillus reuteri probiotics in the treatment of chronic periodontitis: a randomized placebo-controlled study. J Clin Periodontol. 2013;40:1025-1035.
12. Vicario M, Santos A, Violant D, Nart J, Giner L. Clinical changes in periodontal subjects with the probiotic Lactobacillus reuteri Prodentis: a preliminary randomized clinical trial. Acta Odontol Scand. 2013;71:813-819.
13. Vivekananda MR, Vandana KL, Bhat KG. Effect of the probiotic Lactobacilli reuteri (Prodentis) in the management of periodontal disease: A preliminary randomized clinical trial. J Oral Microbiol. 2010;2:5344.
14. Kang MS, Oh JS, Lee HC, et al. Inhibitory effect of Lactobacillus reuteri on periodontopathic and cariogenic bacteria. J Microbiol. 2011;49:193-199.
15. Iniesta M, Herrera D, Montero E, et al. Probiotic effects of orally administered Lactobacillus reuteri-containing tablets on the subgingival and salivary microbiota in patients with gingivitis. A randomized clinical trial. J Clin Periodontol. 2012;39:736-744.
16. Hajishengallis G, Lamont RJ. Dancing with the stars: How choreographed bacterial interactions dictate nososymbiocity and give rise to keystone pathogens, accessory pathogens, and pathobionts. Trends Microbiol. 2016;24:477-489.
17. Ikram S, Hassan N, Raffat MA, Mirza S, Akram Z. Systematic review and meta-analysis of double-blind, placebo-controlled, randomized clinical trials using probiotics in chronic periodontitis. J Investig Clin Dent. 2018;9:e12338.
18. Kumar S, Madurantakam P. Limited evidence shows short-term benefit of probiotics when used as an adjunct to scaling and root planing in the treatment of chronic periodontitis. Evid Based Dent. 2017;18:109-110.
19. Martin-Cabezas R, Davideau J-L, Tenenbaum H, Huck O. Clinical efficacy of probiotics as an adjunctive therapy to non-surgical periodontal treatment of chronic periodontitis: a systematic review and meta-analysis. J Clin Periodontol. 2016;43:520-530.
20. Doron S, Snydman DR. Risk and safety of probiotics. Clin Infect Dis. 2015;60(Suppl 2):S129-S134.
21. Kataria J, Li N, Wynn JL, Neu J. Probiotic microbes: do they need to be alive to be beneficial? Nutr Rev. 2009;67(9):546-550.
22. Taverniti V, Guglielmetti S. The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: Proposal of paraprobiotic concept). Genes Nutr. 2011;6(3):261-274.
23. Pereira T, de Barros P, Fugisaki L, et al. Recent advances in the use of Galleria mellonella model to study immune responses against human pathogens. J Fungi. 2018;4:128.
24. Rossoni RD, de RibeiroF C, dos Santos H, et al. Galleria mellonella as an experimental model to study human oral pathogens. Arch Oral Biol. 2019;101:13-22.
25. Lin X, Chen X, Chen Y, Jiang W, Chen H. The effect of five probiotic lactobacilli strains on the growth and biofilm formation of Streptococcus mutans. Oral Dis. 2015;21:e128-e134.
26. Jorjão AL, Oliveira LD, Scorzoni L, et al. From moths to caterpillars: Ideal conditions for Galleria mellonella rearing for in vivo microbiological studies. Virulence. 2018;9:383-389.
27. dos Santos JD, de Alvarenga JA, Rossoni RD, et al. Immunomodulatory effect of photodynamic therapy in Galleria mellonella infected with Porphyromonas gingivalis. Microb Pathog. 2017;110:507-511.
28. Islam SU. Clinical uses of probiotics. Medicine. 2016;95(5):e2658.
29. Zorzela L, Ardestani SK, McFarland LV, Vohra S. Is there a role for modified probiotics as beneficial microbes: a systematic review of the literature. Benef Microbes. 2017;8(5):739-754.
30. Bermudez-Brito M, Plaza-Díaz J, Muñoz-Quezada S, Gómez-Llorente C, Gil A. Probiotic mechanisms of action. Ann Nutr Metab. 2012;61:160-174.
31. Yang Y, Zhao X, Le M, Zijlstra RT, Gänzle MG. Reutericyclin producing Lactobacillus reuteri modulates development of fecal microbiota in weanling pigs. Front Microbiol. 2015;6:762.
32. Greifová G, Májeková H, Greif G, Body P, Greifová M, Dubničková M. Analysis of antimicrobial and immunomodulatory substances produced by heterofermentative Lactobacillus reuteri. Folia Microbiol (Praha). 2017;62:515-524.
33. Söderling EM, Marttinen AM, Haukioja AL. Probiotic Lactobacilli interfere with Streptococcus mutans biofilm formation in vitro. Curr Microbiol. 2011;62:618-622.
34. Adams CA. The probiotic paradox: live and dead cells are biological response modifiers. Nutr Res Rev. 2010;23:37-46.
35. Iwasaki K, Maeda K, Hidaka K, Nemoto K, Hirose Y, Deguchi S. Daily intake of heat-killed Lactobacillus plantarum L-137 decreases the probing depth in patients undergoing supportive periodontal therapy. Oral Health Prev Dent. 2016;14:207-214.
36. Bergin D, Brennan M, Kavanagh K. Fluctuations in haemocyte density and microbial load may be used as indicators of fungal pathogenicity in larvae of Galleria mellonella. Microbes Infect. 2003;5:1389-1395.